SN-38 is an antineoplastic compound and the active metabolite of irinotecan. It exhibits significantly higher cytotoxic activity than irinotecan itself, with relative potency varying widely in in vitro assays.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 86639-52-3
(3aS,4S,6aR)-Tetrahydro-4-methoxy-furo[3,4-b]furan-2(3H)-one
pharmaceutical raw material
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]oxan-2-yl]methyl acetate
pharmaceutical raw material
Linsitinib
pharmaceutical raw material
Olodaterol
pharmaceutical raw material
10-hydroxycamptothecin
pharmaceutical raw material
Topotecan hydrochloride
pharmaceutical raw material
Topotecan
pharmaceutical raw material
Chimmitecan
pharmaceutical raw material
(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
FJHBVJOVLFPMQE-QFIPXVFZSA-N
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O